These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2688815)

  • 1. Erythropoietin.
    Johnson GR
    Br Med Bull; 1989 Apr; 45(2):506-14. PubMed ID: 2688815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction of anaemia in haemodialysis patients with recombinant human erythropoietin.
    Boran M; Dalva I; Yazicioğlu A; Akbay E; Cetin S
    Int Urol Nephrol; 1993; 25(2):197-203. PubMed ID: 8365853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of transfusion-dependent anaemia of chronic renal failure with recombinant human erythropoietin. A European multicentre study in 142 patients to define dose regimen and safety profile.
    Sundal E; Businger J; Kappeler A
    Nephrol Dial Transplant; 1991; 6(12):955-65. PubMed ID: 1798595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant erythropoietin as treatment for the late hyporegenerative anemia of Rh hemolytic disease.
    Ohls RK; Wirkus PE; Christensen RD
    Pediatrics; 1992 Nov; 90(5):678-80. PubMed ID: 1408538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefits and costs of recombinant human erythropoietin for end-stage renal failure: a review. Benefits and costs of erythropoietin.
    McNamee P; van Doorslaer E; Segaar R
    Int J Technol Assess Health Care; 1993; 9(4):490-504. PubMed ID: 8288425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epoetin beta. A review of its pharmacological properties and clinical use in the management of anaemia associated with chronic renal failure.
    Dunn CJ; Markham A
    Drugs; 1996 Feb; 51(2):299-318. PubMed ID: 8808169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recombinant human erythropoietin stimulates synthesis of fetal hemoglobin in patients with renal anemia treated by repeated hemodialysis].
    Hanicki Z; Sułowicz W; Stepniewski M; Kuźniewski M; Kraśniak A; Kopeć J; Cieszkowska U; Solarska K
    Pol Arch Med Wewn; 1991 Jun; 85(6):352-5. PubMed ID: 1716757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recombinant human erythropoietin].
    Montloin A
    Rev Infirm; 1990 Dec; 40(19):33-4. PubMed ID: 2091207
    [No Abstract]   [Full Text] [Related]  

  • 9. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial.
    Eschbach JW; Egrie JC; Downing MR; Browne JK; Adamson JW
    N Engl J Med; 1987 Jan; 316(2):73-8. PubMed ID: 3537801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin: biology and clinical use.
    Graber SE; Krantz SB
    Hematol Oncol Clin North Am; 1989 Sep; 3(3):369-400. PubMed ID: 2561121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of renal anemia with recombinant human erythropoietin].
    Schaefer RM; Kürner B; Zech M; Krahn R; Heidland A
    Dtsch Med Wochenschr; 1988 Jan; 113(4):125-9. PubMed ID: 3276487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recombinant human erythropoietin].
    Frenken LA; Koene RA
    Ned Tijdschr Geneeskd; 1988 Mar; 132(10):432-4. PubMed ID: 3347279
    [No Abstract]   [Full Text] [Related]  

  • 13. Human recombinant erythropoietin in the treatment of anaemia in chronic haemodialysis patients.
    Sulková S; Kvasnicka J; Kasl M; Kozlová J; Podrouzek P; Bartûsková J; Válek A
    Czech Med; 1990; 13(2-3):98-106. PubMed ID: 2245762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of recombinant human erythropoietin (rHuEpo) in humans.
    Adamson JW; Eschbach JW
    Cancer Surv; 1990; 9(1):157-67. PubMed ID: 2276112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human erythropoietin. Experimental and clinical applications.
    Nielsen OJ
    Dan Med Bull; 1991 Oct; 38(5):355-70. PubMed ID: 1802621
    [No Abstract]   [Full Text] [Related]  

  • 16. Once weekly subcutaneous administration of erythropoietin in haemodialysis patient.
    Hussain R; Naqvi SA
    J Pak Med Assoc; 1994 Apr; 44(4):88-90. PubMed ID: 8072130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epoetin alfa. A review of its clinical efficacy in the management of anaemia associated with renal failure and chronic disease and its use in surgical patients.
    Dunn CJ; Wagstaff AJ
    Drugs Aging; 1995 Aug; 7(2):131-56. PubMed ID: 7579784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of late anemia in Rhesus hemolytic disease: use of recombinant human erythropoietin (a pilot study).
    Ovali F; Samanci N; Dağoğlu T
    Pediatr Res; 1996 May; 39(5):831-4. PubMed ID: 8726237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin use and abuse: When physiology and pharmacology collide.
    Spivak JL
    Adv Exp Med Biol; 2001; 502():207-24. PubMed ID: 11950139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current issues in erythropoietin therapy of renal anemia].
    Zakar G
    Lege Artis Med; 2007 Oct; 17(10):667-73. PubMed ID: 19227596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.